论文部分内容阅读
公司在2002年后顺应了我国医药生产和流通秩序的新形势,内生性的管理改革使得营销能力和盈利质量得到较大改善,并打下了下一步稳健发展的根基。公司2002年主导产品已建立新的营销模式,新销售模式在未来恰当的时机必将推广到整个集团,集团公司推进市场统一的思路正在酝酿之中。全新的营销模式带动了主导产品连续三年的稳健增长。
After 2002, the Company conformed to the new situation of pharmaceutical production and circulation in our country. The endogenous management reform has greatly improved the marketing capability and profitability and laid the foundation for the steady development of the next step. The company’s leading products in 2002 has established a new marketing model, the new sales model will be the right time in the future will be extended to the entire group, the group company to promote market unity is brewing. The new marketing model has led the steady growth of leading products for three consecutive years.